- Home >
- Life Sciences >
- Pharmaceutical >
- Therapy >
Therapy Industry Analysis and Statistics (since 2008 - p4)
All premium reports for Therapy Industry Analysis and Statistics (since 2008 - p4)
91-120 of 150 Premium Reports from 16 Publishers
Cancer Gastrointestinal (Stomach) Cancer
- $ 1 495
- March 2009
Life Science Analytics', Cancer Gastrointestinal (Stomach) Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of gastrointestinal (stomach) cancer drugs by company and by stage as well as a summary of the latest news and developme ...
Industries : Therapy
Cancer Head and Neck Cancer
- $ 1 495
- March 2009
Life Science Analytics', Cancer Head and Neck Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of head and neck cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of ...
Industries : Therapy
Cancer Kidney Cancer
- $ 1 495
- March 2009
Life Science Analytics', Cancer Kidney Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of kidney cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Eac ...
Industries : Therapy
Cancer Liver Cancer
- $ 1 495
- March 2009
Life Science Analytics', Cancer Liver Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of liver cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Each ...
Industries : Therapy
Cancer Lymphoma
- $ 1 495
- March 2009
Life Science Analytics', Cancer Lymphoma contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of lymphoma drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Each Life Sci ...
Industries : Therapy
Cancer Melanoma or Skin Cancer
- $ 1 495
- March 2009
Life Science Analytics', Cancer Melanoma or Skin Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of melanoma or skin cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.Sco ...
Industries : Therapy
Cancer Multiple Myeloma
- $ 1 495
- March 2009
Life Science Analytics', Cancer Multiple Myeloma contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of multiple myeloma drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the repo ...
Industries : Therapy
Cancer Non-Hodgkin Lymphoma
- $ 1 495
- March 2009
Life Science Analytics', Cancer Non-Hodgkin Lymphoma contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of non-hodgkin lymphoma drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of ...
Industries : Therapy
Cancer Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer
- $ 1 495
- March 2009
Life Science Analytics', Cancer Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of non-small-cell lung cancer or lung cancer or small cell lung cancer drugs by compan ...
Industries : Therapy
Cancer Ovarian Cancer
- $ 1 495
- March 2009
Life Science Analytics', Cancer Ovarian Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of ovarian cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:E ...
Industries : Therapy
Cancer Pancreatic Cancer
- $ 1 495
- March 2009
Life Science Analytics', Cancer Pancreatic Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of pancreatic cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the re ...
Industries : Therapy
Cancer Prostate Cancer
- $ 1 495
- March 2009
Life Science Analytics', Cancer Prostate Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of prostate cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report ...
Industries : Therapy
Central Nervous System Alzheimer Disease
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Alzheimer Disease contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of alzheimer disease drugs by company and by stage as well as a summary of the latest news and developments in this area ...
Industries : Therapy
Central Nervous System Amyotrophic Lateral Sclerosis
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Amyotrophic Lateral Sclerosis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of amyotrophic lateral sclerosis drugs by company and by stage as well as a summary of the latest news and d ...
Industries : Therapy
Central Nervous System Anxiety
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Anxiety contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of anxiety drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report ...
Industries : Therapy
Central Nervous System Attention Deficit Disorder with Hyperactivity
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Attention Deficit Disorder with Hyperactivity contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of attention deficit disorder with hyperactivity drugs by company and by stage as well as a ...
Industries : Therapy
Central Nervous System Bipolar Disorder
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Bipolar Disorder contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of bipolar disorder drugs by company and by stage as well as a summary of the latest news and developments in this area.S ...
Industries : Therapy
Central Nervous System Dementia
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Dementia contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of dementia drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the repo ...
Industries : Therapy
Central Nervous System Depression
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Depression contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of depression drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the ...
Industries : Therapy
Central Nervous System Epilepsy
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Epilepsy contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of epilepsy drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the repo ...
Industries : Therapy
Central Nervous System Headache
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Headache contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of headache drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the repo ...
Industries : Therapy
Central Nervous System Huntington Disease
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Huntington Disease contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of huntington disease drugs by company and by stage as well as a summary of the latest news and developments in this a ...
Industries : Therapy
Central Nervous System Insomnia or Sleep Disorders
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Insomnia or Sleep Disorders contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of insomnia or sleep disorders drugs by company and by stage as well as a summary of the latest news and devel ...
Industries : Therapy
Central Nervous System Memory Impairment
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Memory Impairment contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of memory impairment drugs by company and by stage as well as a summary of the latest news and developments in this area ...
Industries : Therapy
Central Nervous System Migraine
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Migraine contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of migraine drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the repo ...
Industries : Therapy
Central Nervous System Multiple Sclerosis
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Multiple Sclerosis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of multiple sclerosis drugs by company and by stage as well as a summary of the latest news and developments in this a ...
Industries : Therapy
Central Nervous System Myasthenia Gravis
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Myasthenia Gravis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of myasthenia gravis drugs by company and by stage as well as a summary of the latest news and developments in this area ...
Industries : Therapy
Central Nervous System Neuralgia
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Neuralgia contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of neuralgia drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the re ...
Industries : Therapy
Central Nervous System Neuropathy
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Neuropathy contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of neuropathy drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the ...
Industries : Therapy
Central Nervous System Obsessive-Compulsive Disorder
- $ 1 495
- March 2009
Life Science Analytics', Central Nervous System Obsessive-Compulsive Disorder contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of obsessive-compulsive disorder drugs by company and by stage as well as a summary of the latest news and d ...
Industries : Therapy
reportlinker.com © Copyright 2009. All rights reserved